Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
449 Polygenic risk scores for liver injury are associated with the risk for autoimmune hepatitis in patients treated with atezolizumab
Compose a Response to This Article
Other responses
No responses have been published for this article.
